Market Forecast By Test Type (Primary Serological Tests, Enzyme Linked Immunosorbent Assay (ELISA), Immunoflurescent Antibody Technique (IFAT), Radio Immunoassay (RIA), Secondary Serological Tests), By Application (Rotavirus Infections, Hepatitis, HIV, Endotoxins, Therapeutic Drug Monitoring, Others), By End-user (Hospital and Clinics, Diagnostic Laboratories, Blood Banks, Diagnostic Laboratories, Others) And Competitive Landscape
| Product Code: ETC7553501 | Publication Date: Sep 2024 | Updated Date: Jan 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
According to 6Wresearch internal database and industry insights, the India Serological Testing Market is projected to grow at a compound annual growth rate (CAGR) of 9.3% during the forecast period from 2026 to 2032.
Below are the evaluations of the year-wise growth rate along with key drivers:
| Year | Est. Annual Growth (%) | Growth Drivers |
| 2021 | 6.8% | High demand for blood screening and routine diagnostic testing in hospitals and laboratories. |
| 2022 | 710.00% | Expansion of diagnostic laboratories and increasing usage of better immunoassay techniques. |
| 2023 | 740.00% | High awareness of early disease diagnosis and increasing testing for infectious and autoimmune diseases. |
| 2024 | 7.8% | Investments in healthcare diagnostics infrastructure and increasing demand for ELISA-based testing. |
| 2025 | 8.2% | Growth in preventive healthcare testing and major use of serological tests in therapeutic drug monitoring. |
The India Serological Testing Market report thoroughly covers the market by test type, application, and end-user. It provides an unbiased and detailed analysis of ongoing market trends, opportunities, challenges, and market drivers, helping stakeholders align their strategies with current and future market dynamics.
| Report Name | India Serological Testing Market |
| Forecast Period | 2026–2032 |
| CAGR | 9.30 |
| Growing Sector | Medical Diagnostics & Healthcare |
India Serological Testing Market is expected to have steady growth as the market is driven by increasing demand for diagnostic accuracy, high risks of infectious and immune-related disorders, and continuous expansion of better diagnostic infrastructure. The growing focus on early disease detection, blood safety, and therapeutic drug monitoring also supports the usage of serological testing in healthcare facilities. Government policies that are focused more on strengthening diagnostic services and public health laboratories, and collaborations between diagnostic companies and healthcare providers are also increasing the growth of the India Serological Testing Market Industry.
Below mentioned are some prominent drivers and their impact on the India Serological Testing Market dynamics:
| Drivers | Primary Segment Affected | Why It Matters (Evidence) |
| Rising Diagnostic Awareness | All Segments | Increased focus on early and accurate diagnosis is driving demand for serological testing. |
| Expansion of Diagnostic Laboratories | Test Type, End-User | The growth of public and private laboratories is improving test availability across regions. |
| Government Healthcare Programs | All Segments | National health initiatives are expanding access to diagnostic services nationwide. |
| Growing Infectious Disease Burden | Application Segments | The rising incidence of hepatitis, HIV, and rotavirus is increasing the need for serological testing. |
| Technological Advancements | ELISA, IFAT | Enhanced sensitivity, accuracy, and reliability are accelerating the adoption of advanced serological methods. |
India Serological Testing Market Size is projected to grow at a CAGR of 9.3% from 2026 to 2032. Some major growth drivers for this market are increasing investments in better diagnostic infrastructure, rising awareness about preventive healthcare, and strong demand for accurate immunological testing. The increased use of ELISA and other new serological techniques improves the efficiency of diagnostics and supportsthe expansion of the market. Increasing usage of serological tests in blood banks and therapeutic drug monitoring is also likely to proliferate India Serological Testing Market Growth.
Below mentioned are some major restraints and their influence on the India Serological Testing Market dynamics:
| Restraints | Primary Segment Affected | What This Means (Evidence) |
| High Equipment Costs | ELISA, RIA | Advanced testing systems require high capital investment, limiting adoption by smaller laboratories. |
| Skilled Workforce Shortage | All Segments | Lack of trained professionals can affect test accuracy and restrict scalability. |
| Regulatory Approvals | All Segments | Lengthy approval processes can delay the introduction of new serological tests. |
| Uneven Healthcare Access | Rural End-Users | Limited diagnostic infrastructure in rural areas restricts market penetration and test volumes. |
| Quality Control Challenges | Diagnostic Laboratories | Ensuring consistent and reliable test quality remains a significant operational challenge. |
India Serological Testing Market faces many challenges, including high prices of better testing systems, a shortage of skilled laboratory professionals, and uneven access to diagnostic facilities in local regions. Regulatory complexities and better-quality needs also create additional operational challenges. Despite all these factors, increasing public and private investment in diagnostics continues to support the stability ofthe market in long-term growth. The major focus on athe ccreditation of the laboratory is improving testing facilities in healthcare facilities. New technological advancements and training policies are also improving workforce and infrastructure gaps, which support better market development.
Major trends that are changing the India Serological Testing Market dynamics include:
Some new investment opportunities in the India Serological Testing Industry are:
Below is the list of prominent companies leading in the India Serological Testing Market
| Company Name | Abbott Laboratories |
| Established Year | 1888 |
| Headquarters | Illinois, United States |
| Official Website | Click Here |
Abbott provides a wide range of serological testing solutions in India, including ELISA-based immunoassays used across hospitals and diagnostic laboratories.
| Company Name | Roche Diagnostics |
| Established Year | 1896 |
| Headquarters | Basel, Switzerland |
| Official Website | Click Here |
Roche Diagnostics offers advanced immunodiagnostic systems and reagents, supporting accurate serological testing across multiple disease areas.
| Company Name | Siemens Healthineers |
| Established Year | 1847 |
| Headquarters | Erlangen, Germany |
| Official Website | Click Here |
Siemens Healthineers delivers automated serology platforms and laboratory solutions widely adopted in large diagnostic centers in India.
| Company Name | Bio-Rad Laboratories |
| Established Year | 1952 |
| Headquarters | California, United States |
| Official Website | Click Here |
Bio-Rad specializes in immunoassay reagents and quality control solutions for serological testing applications.
| Company Name | Transasia Bio-Medicals |
| Established Year | 1979 |
| Headquarters | Mumbai, India |
| Official Website | Click Here |
Transasia Bio-Medicals is a leading domestic player providing cost-effective serological testing kits and diagnostic instruments across India.
According to India’s Government data, they have introduced multiple new initiatives to strengthen diagnostic services in the industry. Programs such as the National Health Mission support the expansion of better laboratory infrastructure in public hospitals. The Indian Council of Medical Research sets better quality standards for diagnostic testing and ensures accuracy and reliability. Incentives for domestic manufacturing of diagnostic kits under healthcare development schemes increase local production and reduce dependency on imports. State-level public health programs also promote wider sales of diagnostic testing in semi-urban and rural regions, which balances healthcare development in the country.
India Serological Testing Market is expected to grow steadily in the coming years due to rising demand in diagnostic, expansion of laboratory networks, and increasing usage of better and advanced serological methods. Continuous support by the government, new technological advancements, and more focus on preventive healthcare will also improve the growth of the market and position India as an important diagnostic testing hub. The major focus on detection of early disease, blood safety, and therapeutic drug monitoring also increases the sales of serological testing in healthcare facilities.
The report offers a comprehensive study of the following market segments and their leading categories:
According to Lakshita, Senior Research Analyst, 6Wresearch, ELISA dominates the India Serological Testing Market due to its high accuracy, scalability, and suitability for detecting antibodies and antigens in a wide range of diseases. Its cost-effectiveness and compatibility with automated systems increase widespread usage in diagnostic laboratories and hospitals.
Hepatitis testing dominates as serological assays are more commonly used for screening, diagnosis, and monitoring of hepatitis infections. High testing volumes and routine screening needs support strong demand in this segment.
Diagnostic Laboratories dominate the India Serological Testing Market Share due to high testing, better infrastructure, and increasing demand for centralized testing facilities. Their ability to offer a large range of serological tests supports leadership in the market.
Market Covered
The report offers a comprehensive study of the following India Serological Testing Market segments:
By Test Type
By Application
By End-user
| 1 Executive Summary |
| 2 Introduction |
| 2.1 Key Highlights of the Report |
| 2.2 Report Description |
| 2.3 Market Scope & Segmentation |
| 2.4 Research Methodology |
| 2.5 Assumptions |
| 3 India Serological Testing Market Overview |
| 3.1 India Country Macro Economic Indicators |
| 3.2 India Serological Testing Market Revenues & Volume, 2022 & 2032F |
| 3.3 India Serological Testing Market - Industry Life Cycle |
| 3.4 India Serological Testing Market - Porter's Five Forces |
| 3.5 India Serological Testing Market Revenues & Volume Share, By Test Type, 2022 & 2032F |
| 3.6 India Serological Testing Market Revenues & Volume Share, By Application, 2022 & 2032F |
| 3.7 India Serological Testing Market Revenues & Volume Share, By End-user, 2022 & 2032F |
| 4 India Serological Testing Market Dynamics |
| 4.1 Impact Analysis |
| 4.2 Market Drivers |
| 4.2.1 Increasing prevalence of infectious diseases in India |
| 4.2.2 Growing demand for accurate diagnostic testing |
| 4.2.3 Technological advancements in serological testing methods |
| 4.3 Market Restraints |
| 4.3.1 Lack of awareness about serological testing in certain regions of India |
| 4.3.2 High cost associated with serological testing procedures |
| 4.3.3 Limited access to healthcare facilities in rural areas |
| 5 India Serological Testing Market Trends |
| 6 India Serological Testing Market, By Types |
| 6.1 India Serological Testing Market, By Test Type |
| 6.1.1 Overview and Analysis |
| 6.1.2 India Serological Testing Market Revenues & Volume, By Test Type, 2022 & 2032F |
| 6.1.3 India Serological Testing Market Revenues & Volume, By Primary Serological Tests, 2022 & 2032F |
| 6.1.4 India Serological Testing Market Revenues & Volume, By Enzyme Linked Immunosorbent Assay (ELISA), 2022 & 2032F |
| 6.1.5 India Serological Testing Market Revenues & Volume, By Immunoflurescent Antibody Technique (IFAT), 2022 & 2032F |
| 6.1.6 India Serological Testing Market Revenues & Volume, By Radio Immunoassay (RIA), 2022 & 2032F |
| 6.1.7 India Serological Testing Market Revenues & Volume, By Secondary Serological Tests, 2022 & 2032F |
| 6.2 India Serological Testing Market, By Application |
| 6.2.1 Overview and Analysis |
| 6.2.2 India Serological Testing Market Revenues & Volume, By Rotavirus Infections, 2022 & 2032F |
| 6.2.3 India Serological Testing Market Revenues & Volume, By Hepatitis, 2022 & 2032F |
| 6.2.4 India Serological Testing Market Revenues & Volume, By HIV, 2022 & 2032F |
| 6.2.5 India Serological Testing Market Revenues & Volume, By Endotoxins, 2022 & 2032F |
| 6.2.6 India Serological Testing Market Revenues & Volume, By Therapeutic Drug Monitoring, 2022 & 2032F |
| 6.2.7 India Serological Testing Market Revenues & Volume, By Others, 2022 & 2032F |
| 6.3 India Serological Testing Market, By End-user |
| 6.3.1 Overview and Analysis |
| 6.3.2 India Serological Testing Market Revenues & Volume, By Hospital and Clinics, 2022 & 2032F |
| 6.3.3 India Serological Testing Market Revenues & Volume, By Diagnostic Laboratories, 2022 & 2032F |
| 6.3.4 India Serological Testing Market Revenues & Volume, By Blood Banks, 2022 & 2032F |
| 6.3.5 India Serological Testing Market Revenues & Volume, By Diagnostic Laboratories, 2022 & 2032F |
| 6.3.6 India Serological Testing Market Revenues & Volume, By Others, 2022 & 2032F |
| 7 India Serological Testing Market Import-Export Trade Statistics |
| 7.1 India Serological Testing Market Export to Major Countries |
| 7.2 India Serological Testing Market Imports from Major Countries |
| 8 India Serological Testing Market Key Performance Indicators |
| 8.1 Percentage increase in the adoption of serological testing in India |
| 8.2 Number of partnerships between healthcare providers and diagnostic testing companies |
| 8.3 Rate of innovation in serological testing technologies |
| 9 India Serological Testing Market - Opportunity Assessment |
| 9.1 India Serological Testing Market Opportunity Assessment, By Test Type, 2022 & 2032F |
| 9.2 India Serological Testing Market Opportunity Assessment, By Application, 2022 & 2032F |
| 9.3 India Serological Testing Market Opportunity Assessment, By End-user, 2022 & 2032F |
| 10 India Serological Testing Market - Competitive Landscape |
| 10.1 India Serological Testing Market Revenue Share, By Companies, 2025 |
| 10.2 India Serological Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
| 11 Company Profiles |
| 12 Recommendations |
| 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here